MIM
IDYA icon

MetLife Investment Management’s IDEAYA Biosciences IDYA Stock Holding History

MetLife Investment Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
48,840
+2,436
+5% +$74.6K 0.01% 1214
2026
Q1 		$1.55M Buy
46,404
+591
+1% +$19.8K 0.01% 1194
2025
Q4 		$1.58M Sell
45,813
-2,695
-6% -$85.9K 0.01% 1195
2025
Q3 		$1.32M Sell
48,508
-1,433
-3% -$34.7K 0.01% 1302
2025
Q2 		$1.05M Hold
49,941
– – 0.01% 1286
2025
Q1 		$818K Sell
49,941
-674
-1% -$14.4K ﹤0.01% 1456
2024
Q4 		$1.3M Buy
50,615
+3,257
+7% +$92.2K 0.01% 1287
2024
Q3 		$1.5M Buy
47,358
+4,164
+10% +$158K 0.01% 1173
2024
Q2 		$1.52M Buy
43,194
+9,574
+28% +$379K 0.01% 1114
2024
Q1 		$1.48M Buy
33,620
+1,988
+6% +$85.5K 0.01% 1091
2023
Q4 		$1.13M Buy
31,632
+2,989
+10% +$89.2K 0.01% 1229
2023
Q3 		$773K Hold
28,643
– – 0.01% 1372
2023
Q2 		$673K Buy
28,643
+5,385
+23% +$111K ﹤0.01% 1501
2023
Q1 		$319K Hold
23,258
– – ﹤0.01% 1916
2022
Q4 		$423K Buy
23,258
+5,987
+35% +$101K ﹤0.01% 1747
2022
Q3 		$258K Hold
17,271
– – ﹤0.01% 2125
2022
Q2 		$238K Hold
17,271
– – ﹤0.01% 2190
2022
Q1 		$193K Buy
17,271
+6,374
+58% +$94K ﹤0.01% 2370
2021
Q4 		$258K Hold
10,897
– – ﹤0.01% 1900
2021
Q3 		$278K Hold
10,897
– – ﹤0.01% 1871
2021
Q2 		$229K Buy
10,897
+3,171
+41% +$65.1K ﹤0.01% 2077
2021
Q1 		$182K Buy
+7,726
New +$149K ﹤0.01% 2105

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

MetLife Investment Management's IDYA Position: Q2 2026 in Review

MetLife Investment Management increased its IDEAYA Biosciences (IDYA) stake by 5.2% in Q2 2026, buying an estimated $74.6K and bringing the position to 48,840 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #1214.

MetLife Investment Management first reported a position in IDYA in Q1 2021 and has held it in 22 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • MetLife Investment Management held 48,840 shares of IDEAYA Biosciences worth $1.82M as of Q2 2026.
  • MetLife Investment Management bought 2,436 IDEAYA Biosciences shares in Q2 2026, an estimated $74.6K.
  • IDEAYA Biosciences made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1214 holding.
  • MetLife Investment Management first reported a position in IDEAYA Biosciences in Q1 2021 and has held it in 22 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.